APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Papillomavirus Protein E7

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Papillomavirus Protein E7 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchHuman Papillomavirus Protein E7 Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Papillomavirus Protein E7 Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Human Papillomavirus Protein E7 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Papillomavirus Protein E7 Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Papillomavirus Protein E7 Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Human Papillomavirus Protein E7 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human Papillomavirus Protein E7 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Papillomavirus Protein E7 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Papillomavirus Protein E7 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Papillomavirus Protein E7 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Papillomavirus Protein E7 include VLPbio, Transgene SA, Touchlight Genetics Ltd, Selecta Biosciences Inc, MedImmune LLC, Inovio Pharmaceuticals Inc, Immunovaccine Inc, iBio Inc and Hookipa Biotech AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Papillomavirus Protein E7 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Papillomavirus Protein E7 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Papillomavirus Protein E7 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Papillomavirus Protein E7 market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Papillomavirus Protein E7 Segment by Company

VLPbio

Transgene SA

Touchlight Genetics Ltd

Selecta Biosciences Inc

MedImmune LLC

Inovio Pharmaceuticals Inc

Immunovaccine Inc

iBio Inc

Hookipa Biotech AG

Genexine Inc

Formune SL

Etubics Corp

Cancer Research Technology Ltd

BioNTech AG

Bioleaders Corp

Advaxis Inc

Abion Inc

Human Papillomavirus Protein E7 Segment by Type

CUE-201

CerviVax

CUE-101

BLSILSB-710c

Others

Human Papillomavirus Protein E7 Segment by Application

Rectal Cancer

Penile Cancer

Anal Cancer

Lung Cancer

Others

Human Papillomavirus Protein E7 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Papillomavirus Protein E7 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Papillomavirus Protein E7 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Papillomavirus Protein E7.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Papillomavirus Protein E7 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Papillomavirus Protein E7 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Papillomavirus Protein E7 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Papillomavirus Protein E7 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Papillomavirus Protein E7 Industry Trends Table 2. Human Papillomavirus Protein E7 Industry Drivers Table 3. Human Papillomavirus Protein E7 Industry Opportunities and Challenges Table 4. Human Papillomavirus Protein E7 Industry Restraints Table 5. Global Human Papillomavirus Protein E7 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Papillomavirus Protein E7 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Papillomavirus Protein E7 Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Human Papillomavirus Protein E7 Sales Market Share by Manufacturers Table 9. Global Human Papillomavirus Protein E7 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Human Papillomavirus Protein E7 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Papillomavirus Protein E7 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Papillomavirus Protein E7 Manufacturers, Product Type & Application Table 13. Global Human Papillomavirus Protein E7 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Papillomavirus Protein E7 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of CUE-201 Table 17. Major Manufacturers of CerviVax Table 18. Major Manufacturers of CUE-101 Table 19. Major Manufacturers of BLSILSB-710c Table 20. Major Manufacturers of Others Table 21. Global Human Papillomavirus Protein E7 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Human Papillomavirus Protein E7 Sales by Type (2021-2026) & (K Units) Table 23. Global Human Papillomavirus Protein E7 Sales by Type (2027-2032) & (K Units) Table 24. Global Human Papillomavirus Protein E7 Sales Market Share by Type (2021-2026) Table 25. Global Human Papillomavirus Protein E7 Sales Market Share by Type (2027-2032) Table 26. Global Human Papillomavirus Protein E7 Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Human Papillomavirus Protein E7 Revenue by Type (2021-2026) & (K Units) Table 28. Global Human Papillomavirus Protein E7 Revenue by Type (2027-2032) & (K Units) Table 29. Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2021-2026) Table 30. Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Rectal Cancer Table 32. Major Manufacturers of Penile Cancer Table 33. Major Manufacturers of Anal Cancer Table 34. Major Manufacturers of Lung Cancer Table 35. Major Manufacturers of Others Table 36. Global Human Papillomavirus Protein E7 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Human Papillomavirus Protein E7 Sales by Application (2021-2026) & (K Units) Table 38. Global Human Papillomavirus Protein E7 Sales by Application (2027-2032) & (K Units) Table 39. Global Human Papillomavirus Protein E7 Sales Market Share by Application (2021-2026) Table 40. Global Human Papillomavirus Protein E7 Sales Market Share by Application (2027-2032) Table 41. Global Human Papillomavirus Protein E7 Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Human Papillomavirus Protein E7 Revenue by Application (2021-2026) & (K Units) Table 43. Global Human Papillomavirus Protein E7 Revenue by Application (2027-2032) & (K Units) Table 44. Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2021-2026) Table 45. Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2027-2032) Table 46. Global Human Papillomavirus Protein E7 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Human Papillomavirus Protein E7 Sales by Region (2021-2026) & (K Units) Table 48. Global Human Papillomavirus Protein E7 Sales Market Share by Region (2021-2026) Table 49. Global Human Papillomavirus Protein E7 Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Human Papillomavirus Protein E7 Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Human Papillomavirus Protein E7 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 53. North America Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 54. Europe Human Papillomavirus Protein E7 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 56. Europe Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Human Papillomavirus Protein E7 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Human Papillomavirus Protein E7 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 63. Global Human Papillomavirus Protein E7 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Human Papillomavirus Protein E7 Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Human Papillomavirus Protein E7 Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Human Papillomavirus Protein E7 Revenue Market Share by Region (2021-2026) Table 67. Global Human Papillomavirus Protein E7 Revenue Market Share by Region (2027-2032) Table 68. VLPbio Company Information Table 69. VLPbio Business Overview Table 70. VLPbio Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. VLPbio Human Papillomavirus Protein E7 Product Portfolio Table 72. VLPbio Recent Development Table 73. Transgene SA Company Information Table 74. Transgene SA Business Overview Table 75. Transgene SA Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Transgene SA Human Papillomavirus Protein E7 Product Portfolio Table 77. Transgene SA Recent Development Table 78. Touchlight Genetics Ltd Company Information Table 79. Touchlight Genetics Ltd Business Overview Table 80. Touchlight Genetics Ltd Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Touchlight Genetics Ltd Human Papillomavirus Protein E7 Product Portfolio Table 82. Touchlight Genetics Ltd Recent Development Table 83. Selecta Biosciences Inc Company Information Table 84. Selecta Biosciences Inc Business Overview Table 85. Selecta Biosciences Inc Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Selecta Biosciences Inc Human Papillomavirus Protein E7 Product Portfolio Table 87. Selecta Biosciences Inc Recent Development Table 88. MedImmune LLC Company Information Table 89. MedImmune LLC Business Overview Table 90. MedImmune LLC Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. MedImmune LLC Human Papillomavirus Protein E7 Product Portfolio Table 92. MedImmune LLC Recent Development Table 93. Inovio Pharmaceuticals Inc Company Information Table 94. Inovio Pharmaceuticals Inc Business Overview Table 95. Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Product Portfolio Table 97. Inovio Pharmaceuticals Inc Recent Development Table 98. Immunovaccine Inc Company Information Table 99. Immunovaccine Inc Business Overview Table 100. Immunovaccine Inc Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Immunovaccine Inc Human Papillomavirus Protein E7 Product Portfolio Table 102. Immunovaccine Inc Recent Development Table 103. iBio Inc Company Information Table 104. iBio Inc Business Overview Table 105. iBio Inc Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. iBio Inc Human Papillomavirus Protein E7 Product Portfolio Table 107. iBio Inc Recent Development Table 108. Hookipa Biotech AG Company Information Table 109. Hookipa Biotech AG Business Overview Table 110. Hookipa Biotech AG Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Hookipa Biotech AG Human Papillomavirus Protein E7 Product Portfolio Table 112. Hookipa Biotech AG Recent Development Table 113. Genexine Inc Company Information Table 114. Genexine Inc Business Overview Table 115. Genexine Inc Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Genexine Inc Human Papillomavirus Protein E7 Product Portfolio Table 117. Genexine Inc Recent Development Table 118. Formune SL Company Information Table 119. Formune SL Business Overview Table 120. Formune SL Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Formune SL Human Papillomavirus Protein E7 Product Portfolio Table 122. Formune SL Recent Development Table 123. Etubics Corp Company Information Table 124. Etubics Corp Business Overview Table 125. Etubics Corp Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Etubics Corp Human Papillomavirus Protein E7 Product Portfolio Table 127. Etubics Corp Recent Development Table 128. Cancer Research Technology Ltd Company Information Table 129. Cancer Research Technology Ltd Business Overview Table 130. Cancer Research Technology Ltd Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Cancer Research Technology Ltd Human Papillomavirus Protein E7 Product Portfolio Table 132. Cancer Research Technology Ltd Recent Development Table 133. BioNTech AG Company Information Table 134. BioNTech AG Business Overview Table 135. BioNTech AG Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. BioNTech AG Human Papillomavirus Protein E7 Product Portfolio Table 137. BioNTech AG Recent Development Table 138. Bioleaders Corp Company Information Table 139. Bioleaders Corp Business Overview Table 140. Bioleaders Corp Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Bioleaders Corp Human Papillomavirus Protein E7 Product Portfolio Table 142. Bioleaders Corp Recent Development Table 143. Advaxis Inc Company Information Table 144. Advaxis Inc Business Overview Table 145. Advaxis Inc Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Advaxis Inc Human Papillomavirus Protein E7 Product Portfolio Table 147. Advaxis Inc Recent Development Table 148. Abion Inc Company Information Table 149. Abion Inc Business Overview Table 150. Abion Inc Human Papillomavirus Protein E7 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Abion Inc Human Papillomavirus Protein E7 Product Portfolio Table 152. Abion Inc Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Human Papillomavirus Protein E7 Distributors List Table 156. Human Papillomavirus Protein E7 Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Human Papillomavirus Protein E7 Product Image Figure 2. Global Human Papillomavirus Protein E7 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Papillomavirus Protein E7 Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Papillomavirus Protein E7 Sales (2021-2032) & (K Units) Figure 5. Global Human Papillomavirus Protein E7 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Papillomavirus Protein E7 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. CUE-201 Image Figure 9. CerviVax Image Figure 10. CUE-101 Image Figure 11. BLSILSB-710c Image Figure 12. Others Image Figure 13. Global Human Papillomavirus Protein E7 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Human Papillomavirus Protein E7 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Human Papillomavirus Protein E7 Sales Market Share by Type (2021-2032) Figure 16. Global Human Papillomavirus Protein E7 Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Human Papillomavirus Protein E7 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2021-2032) Figure 19. Rectal Cancer Image Figure 20. Penile Cancer Image Figure 21. Anal Cancer Image Figure 22. Lung Cancer Image Figure 23. Others Image Figure 24. Global Human Papillomavirus Protein E7 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Human Papillomavirus Protein E7 Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Human Papillomavirus Protein E7 Sales Market Share by Application (2021-2032) Figure 27. Global Human Papillomavirus Protein E7 Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Human Papillomavirus Protein E7 Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2021-2032) Figure 30. North America Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Human Papillomavirus Protein E7 Sales Market Share by Country (2021-2032) Figure 32. U.S. Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Human Papillomavirus Protein E7 Sales Market Share by Country (2021-2032) Figure 37. Germany Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Human Papillomavirus Protein E7 Sales Market Share by Country (2021-2032) Figure 44. China Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Human Papillomavirus Protein E7 Sales Market Share by Country (2021-2032) Figure 52. Brazil Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Human Papillomavirus Protein E7 Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Human Papillomavirus Protein E7 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Human Papillomavirus Protein E7 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Figure 63. North America Human Papillomavirus Protein E7 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Figure 65. Europe Human Papillomavirus Protein E7 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Human Papillomavirus Protein E7 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Human Papillomavirus Protein E7 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Human Papillomavirus Protein E7 Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Human Papillomavirus Protein E7 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • CUE-201
  • CerviVax
  • CUE-101
  • BLSILSB-710c
  • Others
Applications
  • Rectal Cancer
  • Penile Cancer
  • Anal Cancer
  • Lung Cancer
  • Others
Companies covered
  • VLPbio
  • Transgene SA
  • Touchlight Genetics Ltd
  • Selecta Biosciences Inc
  • MedImmune LLC
  • Inovio Pharmaceuticals Inc
  • Immunovaccine Inc
  • iBio Inc
  • Hookipa Biotech AG
  • Genexine Inc
  • Formune SL
  • Etubics Corp
  • Cancer Research Technology Ltd
  • BioNTech AG
  • Bioleaders Corp
  • Advaxis Inc
  • Abion Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Papillomavirus Protein E7 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Papillomavirus Protein E7 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Papillomavirus Protein E7 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Papillomavirus Protein E7 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Papillomavirus Protein E7 Market Dynamics
  1. 2.1 Human Papillomavirus Protein E7 Industry Trends
  2. 2.2 Human Papillomavirus Protein E7 Industry Drivers
  3. 2.3 Human Papillomavirus Protein E7 Industry Opportunities and Challenges
  4. 2.4 Human Papillomavirus Protein E7 Industry Restraints
3 Human Papillomavirus Protein E7 Market by Manufacturers
  1. 3.1 Global Human Papillomavirus Protein E7 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Papillomavirus Protein E7 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Papillomavirus Protein E7 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Papillomavirus Protein E7 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Papillomavirus Protein E7 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Papillomavirus Protein E7 Manufacturers, Product Type & Application
  7. 3.7 Global Human Papillomavirus Protein E7 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Papillomavirus Protein E7 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Papillomavirus Protein E7 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Papillomavirus Protein E7 Tier 1, Tier 2, and Tier 3
4 Human Papillomavirus Protein E7 Market by Type
  1. 4.1 Human Papillomavirus Protein E7 Type Introduction
  2. 4.1.1 CUE-201
  3. 4.1.2 CerviVax
  4. 4.1.3 CUE-101
  5. 4.1.4 BLSILSB-710c
  6. 4.1.5 Others
  7. 4.2 Global Human Papillomavirus Protein E7 Sales by Type
  8. 4.2.1 Global Human Papillomavirus Protein E7 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Human Papillomavirus Protein E7 Sales by Type (2021-2032)
  10. 4.2.3 Global Human Papillomavirus Protein E7 Sales Market Share by Type (2021-2032)
  11. 4.3 Global Human Papillomavirus Protein E7 Revenue by Type
  12. 4.3.1 Global Human Papillomavirus Protein E7 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Human Papillomavirus Protein E7 Revenue by Type (2021-2032)
  14. 4.3.3 Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2021-2032)
5 Human Papillomavirus Protein E7 Market by Application
  1. 5.1 Human Papillomavirus Protein E7 Application Introduction
  2. 5.1.1 Rectal Cancer
  3. 5.1.2 Penile Cancer
  4. 5.1.3 Anal Cancer
  5. 5.1.4 Lung Cancer
  6. 5.1.5 Others
  7. 5.2 Global Human Papillomavirus Protein E7 Sales by Application
  8. 5.2.1 Global Human Papillomavirus Protein E7 Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Human Papillomavirus Protein E7 Sales by Application (2021-2032)
  10. 5.2.3 Global Human Papillomavirus Protein E7 Sales Market Share by Application (2021-2032)
  11. 5.3 Global Human Papillomavirus Protein E7 Revenue by Application
  12. 5.3.1 Global Human Papillomavirus Protein E7 Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Human Papillomavirus Protein E7 Revenue by Application (2021-2032)
  14. 5.3.3 Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2021-2032)
6 Global Human Papillomavirus Protein E7 Sales by Region
  1. 6.1 Global Human Papillomavirus Protein E7 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Papillomavirus Protein E7 Sales by Region (2021-2032)
  3. 6.2.1 Global Human Papillomavirus Protein E7 Sales by Region (2021-2026)
  4. 6.2.2 Global Human Papillomavirus Protein E7 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Papillomavirus Protein E7 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Papillomavirus Protein E7 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Papillomavirus Protein E7 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Papillomavirus Protein E7 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Papillomavirus Protein E7 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Papillomavirus Protein E7 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Papillomavirus Protein E7 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Papillomavirus Protein E7 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Papillomavirus Protein E7 Revenue by Region
  1. 7.1 Global Human Papillomavirus Protein E7 Revenue by Region
  2. 7.1.1 Global Human Papillomavirus Protein E7 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Papillomavirus Protein E7 Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Papillomavirus Protein E7 Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Papillomavirus Protein E7 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Papillomavirus Protein E7 Revenue (2021-2032)
  8. 7.2.2 North America Human Papillomavirus Protein E7 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Papillomavirus Protein E7 Revenue (2021-2032)
  11. 7.3.2 Europe Human Papillomavirus Protein E7 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Papillomavirus Protein E7 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Papillomavirus Protein E7 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Papillomavirus Protein E7 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Papillomavirus Protein E7 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 VLPbio
  2. 8.1.1 VLPbio Company Information
  3. 8.1.2 VLPbio Business Overview
  4. 8.1.3 VLPbio Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 VLPbio Human Papillomavirus Protein E7 Product Portfolio
  6. 8.1.5 VLPbio Recent Developments
  7. 8.2 Transgene SA
  8. 8.2.1 Transgene SA Company Information
  9. 8.2.2 Transgene SA Business Overview
  10. 8.2.3 Transgene SA Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Transgene SA Human Papillomavirus Protein E7 Product Portfolio
  12. 8.2.5 Transgene SA Recent Developments
  13. 8.3 Touchlight Genetics Ltd
  14. 8.3.1 Touchlight Genetics Ltd Company Information
  15. 8.3.2 Touchlight Genetics Ltd Business Overview
  16. 8.3.3 Touchlight Genetics Ltd Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Touchlight Genetics Ltd Human Papillomavirus Protein E7 Product Portfolio
  18. 8.3.5 Touchlight Genetics Ltd Recent Developments
  19. 8.4 Selecta Biosciences Inc
  20. 8.4.1 Selecta Biosciences Inc Company Information
  21. 8.4.2 Selecta Biosciences Inc Business Overview
  22. 8.4.3 Selecta Biosciences Inc Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Selecta Biosciences Inc Human Papillomavirus Protein E7 Product Portfolio
  24. 8.4.5 Selecta Biosciences Inc Recent Developments
  25. 8.5 MedImmune LLC
  26. 8.5.1 MedImmune LLC Company Information
  27. 8.5.2 MedImmune LLC Business Overview
  28. 8.5.3 MedImmune LLC Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MedImmune LLC Human Papillomavirus Protein E7 Product Portfolio
  30. 8.5.5 MedImmune LLC Recent Developments
  31. 8.6 Inovio Pharmaceuticals Inc
  32. 8.6.1 Inovio Pharmaceuticals Inc Company Information
  33. 8.6.2 Inovio Pharmaceuticals Inc Business Overview
  34. 8.6.3 Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Product Portfolio
  36. 8.6.5 Inovio Pharmaceuticals Inc Recent Developments
  37. 8.7 Immunovaccine Inc
  38. 8.7.1 Immunovaccine Inc Company Information
  39. 8.7.2 Immunovaccine Inc Business Overview
  40. 8.7.3 Immunovaccine Inc Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Immunovaccine Inc Human Papillomavirus Protein E7 Product Portfolio
  42. 8.7.5 Immunovaccine Inc Recent Developments
  43. 8.8 iBio Inc
  44. 8.8.1 iBio Inc Company Information
  45. 8.8.2 iBio Inc Business Overview
  46. 8.8.3 iBio Inc Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 iBio Inc Human Papillomavirus Protein E7 Product Portfolio
  48. 8.8.5 iBio Inc Recent Developments
  49. 8.9 Hookipa Biotech AG
  50. 8.9.1 Hookipa Biotech AG Company Information
  51. 8.9.2 Hookipa Biotech AG Business Overview
  52. 8.9.3 Hookipa Biotech AG Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hookipa Biotech AG Human Papillomavirus Protein E7 Product Portfolio
  54. 8.9.5 Hookipa Biotech AG Recent Developments
  55. 8.10 Genexine Inc
  56. 8.10.1 Genexine Inc Company Information
  57. 8.10.2 Genexine Inc Business Overview
  58. 8.10.3 Genexine Inc Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Genexine Inc Human Papillomavirus Protein E7 Product Portfolio
  60. 8.10.5 Genexine Inc Recent Developments
  61. 8.11 Formune SL
  62. 8.11.1 Formune SL Company Information
  63. 8.11.2 Formune SL Business Overview
  64. 8.11.3 Formune SL Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Formune SL Human Papillomavirus Protein E7 Product Portfolio
  66. 8.11.5 Formune SL Recent Developments
  67. 8.12 Etubics Corp
  68. 8.12.1 Etubics Corp Company Information
  69. 8.12.2 Etubics Corp Business Overview
  70. 8.12.3 Etubics Corp Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Etubics Corp Human Papillomavirus Protein E7 Product Portfolio
  72. 8.12.5 Etubics Corp Recent Developments
  73. 8.13 Cancer Research Technology Ltd
  74. 8.13.1 Cancer Research Technology Ltd Company Information
  75. 8.13.2 Cancer Research Technology Ltd Business Overview
  76. 8.13.3 Cancer Research Technology Ltd Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cancer Research Technology Ltd Human Papillomavirus Protein E7 Product Portfolio
  78. 8.13.5 Cancer Research Technology Ltd Recent Developments
  79. 8.14 BioNTech AG
  80. 8.14.1 BioNTech AG Company Information
  81. 8.14.2 BioNTech AG Business Overview
  82. 8.14.3 BioNTech AG Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BioNTech AG Human Papillomavirus Protein E7 Product Portfolio
  84. 8.14.5 BioNTech AG Recent Developments
  85. 8.15 Bioleaders Corp
  86. 8.15.1 Bioleaders Corp Company Information
  87. 8.15.2 Bioleaders Corp Business Overview
  88. 8.15.3 Bioleaders Corp Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bioleaders Corp Human Papillomavirus Protein E7 Product Portfolio
  90. 8.15.5 Bioleaders Corp Recent Developments
  91. 8.16 Advaxis Inc
  92. 8.16.1 Advaxis Inc Company Information
  93. 8.16.2 Advaxis Inc Business Overview
  94. 8.16.3 Advaxis Inc Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Advaxis Inc Human Papillomavirus Protein E7 Product Portfolio
  96. 8.16.5 Advaxis Inc Recent Developments
  97. 8.17 Abion Inc
  98. 8.17.1 Abion Inc Company Information
  99. 8.17.2 Abion Inc Business Overview
  100. 8.17.3 Abion Inc Human Papillomavirus Protein E7 Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Abion Inc Human Papillomavirus Protein E7 Product Portfolio
  102. 8.17.5 Abion Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Papillomavirus Protein E7 Value Chain Analysis
  2. 9.1.1 Human Papillomavirus Protein E7 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Papillomavirus Protein E7 Production Mode & Process
  6. 9.2 Human Papillomavirus Protein E7 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Papillomavirus Protein E7 Distributors
  9. 9.2.3 Human Papillomavirus Protein E7 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst